Is Now The Time To Look At Buying STERIS plc (NYSE:STE)?

In This Article:

STERIS plc (NYSE:STE) is currently undervalued, with an intrinsic value of $366.87 compared to its current trading price of $225. The company's share price is considered stable, which may mean it could take time to reach its intrinsic value. Despite this, STERIS has a positive outlook, with earnings expected to increase by 62% over the next few years. This growth is not yet fully reflected in the current share price, making it a potential buying opportunity. Retail investors may consider increasing their holdings or buying into the stock, but should also consider other factors such as capital structure and management track record before making a decision.

Generated by Yahoo Finance AI
Was this helpful?

STERIS plc (NYSE:STE) saw significant share price movement during recent months on the NYSE, rising to highs of US$247 and falling to the lows of US$221. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether STERIS' current trading price of US$225 reflective of the actual value of the large-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at STERIS’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for STERIS

Is STERIS Still Cheap?

Great news for investors – STERIS is still trading at a fairly cheap price. According to our valuation, the intrinsic value for the stock is $366.87, but it is currently trading at US$225 on the share market, meaning that there is still an opportunity to buy now. What’s more interesting is that, STERIS’s share price is theoretically quite stable, which could mean two things: firstly, it may take the share price a while to move to its intrinsic value, and secondly, there may be less chances to buy low in the future once it reaches that value. This is because the stock is less volatile than the wider market given its low beta.

What kind of growth will STERIS generate?

earnings-and-revenue-growth
NYSE:STE Earnings and Revenue Growth November 3rd 2024

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. STERIS' earnings over the next few years are expected to increase by 62%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What This Means For You

Are you a shareholder? Since STE is currently undervalued, it may be a great time to increase your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

Are you a potential investor? If you’ve been keeping an eye on STE for a while, now might be the time to make a leap. Its buoyant future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy STE. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed buy.